TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Osteopore Ltd. ( (AU:OSX) ) has provided an announcement.
Osteopore Limited has announced a further drawdown of its Tranche 1 redeemable convertible notes, raising an additional A$250,000. This funding, part of a larger A$20 million subscription agreement with Advance Opportunities Fund, will support the company’s ongoing business operations and future development projects. The strategic financial move is expected to bolster Osteopore’s market positioning and facilitate the advancement of its innovative regenerative medicine solutions.
More about Osteopore Ltd.
Osteopore Limited is a Singapore-founded regenerative medicine company and a global leader in 3D-printed biomimetic and bioresorbable implants. The company focuses on commercializing products that stimulate natural bone healing across multiple segments. Osteopore’s patented scaffolds, made from naturally dissolving polymers, guide and nurture bone-forming cells, significantly reducing post-surgery complications associated with permanent bone implants.
Average Trading Volume: 1,502,014
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.3M
See more data about OSX stock on TipRanks’ Stock Analysis page.